Astellas Pharma Inc. offers to acquire OSI Pharmaceuticals for $52.00 per share in cash
Astellas Pharma Inc., a global pharmaceutical company, will commence a tender offer to acquire all outstanding shares of common stock of OSI Pharmaceuticals for $52.00 per share in cash, or an aggregate of approximately $3.5 billion on a fully diluted basis.
Astellas has expanded its business in South East Europe, by establishing a new subsidiary, Astellas Pharma doo in Slovenia.